L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,336,804	546,706	657,862	524,021	830,267	754,757
Market Cap Growth	22.42%	-16.90%	25.54%	-36.88%	10.01%	300.62%
Enterprise Value	1,391,821	613,095	657,447	594,079	823,218	740,027
Last Close Price	54300.00	24100.00	28934.68	22968.91	36314.70	34182.85
PE Ratio	10.89	3.88	13.60	115.32	60.10	69.80
Forward PE	-	32.07	37.96	88.62	80.93	84.66
PS Ratio	17.59	7.58	9.98	9.97	18.18	22.89
PB Ratio	4.13	1.86	4.19	4.86	8.90	12.32
P/TBV Ratio	11.83	6.42	4.52	5.55	9.90	13.11
P/FCF Ratio	-	-	-	-	1266.25	171.43
P/OCF Ratio	1707.82	-	-	-	76.13	101.73
EV/Sales Ratio	18.32	8.50	9.97	11.30	18.02	22.44
EV/EBITDA Ratio	245.51	65.95	47.70	42.46	51.22	83.04
EV/EBIT Ratio	-	241.18	80.87	62.64	62.51	101.04
EV/FCF Ratio	-241.06	-	-	-	1255.50	168.08
Debt / Equity Ratio	0.32	0.42	0.52	0.76	0.07	0.25
Debt / EBITDA Ratio	18.44	13.33	5.96	5.86	0.43	1.69
Debt / FCF Ratio	-	-	-	-	10.42	3.41
Asset Turnover	0.20	0.20	0.28	0.34	0.49	0.45
Inventory Turnover	0.82	0.78	0.80	1.10	1.69	1.87
Quick Ratio	0.61	0.49	0.77	1.37	5.77	9.97
Current Ratio	1.04	0.84	1.28	3.43	8.45	12.38
Return on Equity (ROE)	51.63%	63.44%	36.92%	5.66%	20.17%	19.99%
Return on Assets (ROA)	-0.33%	0.43%	2.20%	3.86%	8.76%	6.24%
Return on Capital (ROIC)	-0.37%	0.48%	2.37%	4.09%	9.33%	6.62%
Return on Capital Employed (ROCE)	-	0.80%	5.10%	5.20%	12.90%	9.50%
Earnings Yield	9.30%	25.80%	7.35%	0.87%	1.66%	1.43%
FCF Yield	-0.43%	-2.43%	-5.57%	-8.32%	0.08%	0.58%
Dividend Yield	0.08%	0.21%	-	-	-	-
Payout Ratio	0.90%	1.61%	2.31%	24.54%	7.80%	6.74%
Buyback Yield / Dilution	-2.88%	-1.90%	-8.98%	-1.74%	-1.83%	0.33%
Total Shareholder Return	-2.80%	-1.69%	-8.98%	-1.74%	-1.83%	0.33%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.